Skip to content
Triangle logo TriangleGet started
← Full study record

NCT01869777 · OUTCOME

Treatment Related Mortality Defined as the Percent of Patients no Longer Alive at 60 Days After Registration

Bioelectrical Impedance Measurement for Predicting Treatment Outcome in Patients With Newly Diagnosed Acute Leukemia · Source last updated 2020-08-13

Results reported by the registry submitting party. Population, time horizon, units and missing values must be read together.

Measure
COUNT_OF_PARTICIPANTS
Unit
Participants
Interval / dispersion
Not reported
Time frame
60 days

What was measured

Logistic regression will be used to analyze the association between standardized phase angle and 60 day mortality. 60 day mortality rate is defined as the percent of patients no longer alive at 60 days after registration. Patients that are discharged to hospice care before 60 days without a known date of death will be counted towards 60 day mortality

Groups in this outcome

Diagnostic (Bioelectric Impedance Analysis)

Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis

Group identifiers and denominators belong to this outcome only. They may differ in another outcome or in safety reporting.

Analysis denominator · Participants

GroupSource count
Diagnostic (Bioelectric Impedance Analysis)101

Reported measurements

Source class 1

Alive

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Diagnostic (Bioelectric Impedance Analysis)91Not reportedNot reportedNot reportedNot reported

Deceased

Values in Participants · Interval/dispersion: Not reported
GroupValueSpreadLowerUpperComment
Diagnostic (Bioelectric Impedance Analysis)10Not reportedNot reportedNot reportedNot reported
Complete source fields
classes
  1. categories
    1. measurements
      1. group Id
        OG000
        value
        91
      title
      Alive
    2. measurements
      1. group Id
        OG000
        value
        10
      title
      Deceased
denoms
  1. counts
    1. group Id
      OG000
      value
      101
    units
    Participants
description
Logistic regression will be used to analyze the association between standardized phase angle and 60 day mortality. 60 day mortality rate is defined as the percent of patients no longer alive at 60 days after registration. Patients that are discharged to hospice care before 60 days without a known date of death will be counted towards 60 day mortality
groups
  1. description
    Patients undergo bioelectrical impedance phase angle measurement on day 1 of treatment. Patients with AML undergo a second measurement just prior to the nadir marrow. Patients also undergo bioelectrical impedance measurements prior to any invasive procedures (bone marrow biopsy, leukapheresis, PICC line placement, etc.). bioelectric impedance analysis: Undergo bioelectric impedance analysis
    id
    OG000
    title
    Diagnostic (Bioelectric Impedance Analysis)
param Type
COUNT_OF_PARTICIPANTS
reporting Status
POSTED
time Frame
60 days
title
Treatment Related Mortality Defined as the Percent of Patients no Longer Alive at 60 Days After Registration
type
PRIMARY
unit Of Measure
Participants

Download exact source JSON → · Snapshot ctgov-results-25a395029948b04d52b1253f

Preserved source evidence · Not medical advice